Shire/Noven Gain Additional Quota For Daytrana Active Ingredient
This article was originally published in The Pink Sheet Daily
Executive Summary
DEA approves quota to manufacture additional quantities of methylphenidate used in the transdermal attention deficit/hyperactivity disorder treatment in 2006.